The Pursuit of Noninvasive Diagnosis of Lung Cancer

Seminars in Respiratory and Critical Care Medicine

Volumn 37, Issue 5, 2016, Pages 670-680

  Atwater, Thomas ^a   Cook, Christine M ^a   Massion, Pierre P ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

biomarkers; clinical utility; early detection; indeterminate pulmonary nodule

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; DNA; MICRORNA; TRANSFER RNA; TUMOR ANTIGEN; VOLATILE ORGANIC COMPOUND; TUMOR MARKER;

AIRWAY EPITHELIAL CELL; ARTICLE; AUTOMATION; BIOMICS; BRONCHIAL EPITHELIAL CELL; CANCER DIAGNOSIS; CIRCULATING TUMOR CELL; CLINICAL MODEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENOME; HUMAN; IMAGE ANALYSIS; IMAGING; LUNG CANCER; MODEL; NODULE SIZE; NON INVASIVE PROCEDURE; ONCOLOGICAL PARAMETERS; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE STRUCTURAL IMAGE ANALYSIS; RADIOMICS; REPRODUCIBILITY; VALIDATION STUDY; LUNG NODULE; LUNG TUMOR; MULTIPLE PULMONARY NODULES;

BIOMARKERS, TUMOR; HUMANS; LUNG NEOPLASMS; MULTIPLE PULMONARY NODULES; SOLITARY PULMONARY NODULE;

EID: 84991716191     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0036-1592314     Document Type: Article

References (87)

1. CDC Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2015
2. SEER National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch; 2014
3. Goldstraw P Crowley J Chansky K, et al; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2007 2 8 706 714
4. Gould M K Tang T Liu I L, et al. Recent trends in the identification of incidental pulmonary nodules Am J Respir Crit Care Med 2015 192 10 1208 1214
5. Aberle D R Adams A M Berg C D, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 2011 365 5 395 409
6. Yang W Sun W Li Q, et al. Diagnostic accuracy of CT-guided transthoracic needle biopsy for solitary pulmonary nodules PLoS ONE 2015 10 6 e0131373
7. Yeow K M See L C Lui K W, et al. Risk factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions J Vasc Interv Radiol 2001 12 11 1305 1312
8. Tanner N T Aggarwal J Gould M K, et al. Management of pulmonary nodules by community pulmonologists: a multicenter observational study Chest 2015 148 6 1405 1414
9. Deppen S Putnam J B Jr Andrade G, et al. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease Ann Thorac Surg 2011 92 2 428 432, discussion 433
10. Deppen S A Blume J D Kensinger C D, et al. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis JAMA 2014 312 12 1227 1236
11. Atwater T Massion P P Biomarkers of risk to develop lung cancer in the new screening era Ann Transl Med 2016 4 8 158
12. Shepherd F A Rodrigues Pereira J Ciuleanu T, et al; National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 2005 353 2 123 132
13. Hirsch F R Varella-Garcia M Bunn P A Jr, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 2003 21 20 3798 3807
14. Thatcher N Chang A Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) Lancet 2005 366 9496 1527 1537
15. Winton T Livingston R Johnson D, et al; National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 2005 352 25 2589 2597
16. Tsao M S Aviel-Ronen S Ding K, et al. Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer J Clin Oncol 2007 25 33 5240 5247
17. Zhu C Q da Cunha Santos G Ding K, et al; National Cancer Institute of Canada Clinical Trials Group Study BR.21. Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 J Clin Oncol 2008 26 26 4268 4275
18. Pepe M S Feng Z Janes H Bossuyt P M Potter J D Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design J Natl Cancer Inst 2008 100 20 1432 1438
19. Institute of Medicine In: Academies IoMotN ed. Advising the Nation Improving Health 2012
20. Hayes D F Bast R C Desch C E, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers J Natl Cancer Inst 1996 88 20 1456 1466
21. Botkin J R Teutsch S M Kaye C I, et al; EGAPP Working Group. Outcomes of interest in evidence-based evaluations of genetic tests Genet Med 2010 12 4 228 235
22. Erasmus J J Connolly J E McAdams H P Roggli V L Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions Radiographics 2000 20 1 43 58
23. Zerhouni E A Stitik F P Siegelman S S, et al. CT of the pulmonary nodule: a cooperative study Radiology 1986 160 2 319 327
24. Gurney J W Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory Radiology 1993 186 2 405 413
25. MacMahon H Austin J H Gamsu G, et al; Fleischner Society. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society Radiology 2005 237 2 395 400
26. Eisenhauer E A Therasse P Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 2009 45 2 228 247
27. Naidich D P Bankier A A MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society Radiology 2013 266 1 304 317
28. Gierada D S Pinsky P Nath H Chiles C Duan F Aberle D R Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination J Natl Cancer Inst 2014 106 11
29. Henschke C I Yip R Yankelevitz D F Smith J P; International Early Lung Cancer Action Program Investigators*. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study Ann Intern Med 2013 158 4 246 252
30. Quint L E Cheng J Schipper M Chang A C Kalemkerian G Lung lesion doubling times: values and variability based on method of volume determination Clin Radiol 2008 63 1 41 48
31. van Klaveren R J Oudkerk M Prokop M, et al. Management of lung nodules detected by volume CT scanning N Engl J Med 2009 361 23 2221 2229
32. Smith G T Rahman A R Li M, et al. Reproducibility of volumetric computed tomography of stable small pulmonary nodules with implications on estimated growth rate and optimal scan interval PLoS ONE 2015 10 9 e0138144
33. Swensen S J Silverstein M D Ilstrup D M Schleck C D Edell E S The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules Arch Intern Med 1997 157 8 849 855
34. Gould M K Ananth L Barnett P G; Veterans Affairs SNAP Cooperative Study Group. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules Chest 2007 131 2 383 388
35. McWilliams A Tammemagi M C Mayo J R, et al. Probability of cancer in pulmonary nodules detected on first screening CT N Engl J Med 2013 369 10 910 919
36. Deppen S A Blume J D Aldrich M C, et al. Predicting lung cancer prior to surgical resection in patients with lung nodules J Thorac Oncol 2014 9 10 1477 1484
37. Gevaert O Xu J Hoang C D, et al. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data - methods and preliminary results Radiology 2012 264 2 387 396
38. Ravanelli M Farina D Morassi M, et al. Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy Eur Radiol 2013 23 12 3450 3455
39. Maldonado F Boland J M Raghunath S, et al. Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY) - a pilot study J Thorac Oncol 2013 8 4 452 460
40. Raghunath S Maldonado F Rajagopalan S, et al. Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography J Thorac Oncol 2014 9 11 1698 1703
41. Maldonado F Duan F Raghunath S M, et al. Noninvasive computed tomography-based risk stratification of lung adenocarcinomas in the National Lung Screening Trial Am J Respir Crit Care Med 2015 192 6 737 744
42. Aerts H J Velazquez E R Leijenaar R T, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach Nat Commun 2014 5 4006
43. Lambin P Rios-Velazquez E Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis Eur J Cancer 2012 48 4 441 446
44. Kumar V Gu Y Basu S, et al. Radiomics: the process and the challenges Magn Reson Imaging 2012 30 9 1234 1248
45. Segal E Friedman N Koller D Regev A A module map showing conditional activity of expression modules in cancer Nat Genet 2004 36 10 1090 1098
46. Mulshine J L Gierada D S Armato S G III, et al. Role of the Quantitative Imaging Biomarker Alliance in optimizing CT for the evaluation of lung cancer screen-detected nodules J Am Coll Radiol 2015 12 4 390 395
47. Hori S S Gambhir S S Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations Sci Transl Med 2011 3 109 109ra116
48. Thorpe J D Duan X Forrest R, et al. Effects of blood collection conditions on ovarian cancer serum markers PLoS ONE 2007 2 12 e1281
49. Silvestri G A Vachani A Whitney D, et al; AEGIS Study Team. A bronchial genomic classifier for the diagnostic evaluation of lung cancer N Engl J Med 2015 373 3 243 251
50. Jett J R Peek L J Fredericks L Jewell W Pingleton W W Robertson J F Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: an evaluation of its performance in routine clinical practice Lung Cancer 2014 83 1 51 55
51. Chapman C J Murray A McElveen J E, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure Thorax 2008 63 3 228 233
52. Murray A Chapman C J Healey G, et al. Technical validation of an autoantibody test for lung cancer Ann Oncol 2010 21 8 1687 1693
53. Boyle P Chapman C J Holdenrieder S, et al. Clinical validation of an autoantibody test for lung cancer Ann Oncol 2011 22 2 383 389
54. Sozzi G Boeri M Rossi M, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study J Clin Oncol 2014 32 8 768 773
55. Mitchell P S Parkin R K Kroh E M, et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 2008 105 30 10513 10518
56. Li S Zhu J Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection Circulation 2011 124 2 175 184
57. Boeri M Verri C Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer Proc Natl Acad Sci U S A 2011 108 9 3713 3718
58. Xing L Su J Guarnera M A, et al. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules Clin Cancer Res 2015 21 2 484 489
59. Huang Y Hu Q Deng Z Hang Y Wang J Wang K MicroRNAs in body fluids as biomarkers for non-small cell lung cancer: a systematic review Technol Cancer Res Treat 2014 13 3 277 287
60. Wang C Ding M Xia M, et al. A five-miRNA panel identified from a multicentric case-control study serves as a novel diagnostic tool for ethnically diverse non-small-cell lung cancer patients EBioMedicine 2015 2 10 1377 1385
61. Zeng G Q Yi H Zhang P F, et al. The function and significance of SELENBP1 downregulation in human bronchial epithelial carcinogenic process PLoS ONE 2013 8 8 e71865
62. Lehtonen S T Svensk A M Soini Y, et al. Peroxiredoxins, a novel protein family in lung cancer Int J Cancer 2004 111 4 514 521
63. Li X J Hayward C Fong P Y, et al. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules Sci Transl Med 2013 5 207 207ra142
64. Vachani A Hammoud Z Springmeyer S, et al. Clinical utility of a plasma protein classifier for indeterminate lung nodules Lung 2015 193 6 1023 1027
65. Mazzone P J Wang X F Xu Y, et al. Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer J Thorac Oncol 2012 7 1 137 142
66. Peled N Hakim M Bunn P A Jr, et al. Non-invasive breath analysis of pulmonary nodules J Thorac Oncol 2012 7 10 1528 1533
67. Mazzone P J Wang X F Lim S, et al. Progress in the development of volatile exhaled breath signatures of lung cancer Ann Am Thorac Soc 2015 12 5 752 757
68. Fernandes M P Venkatesh S Sudarshan B G Early detection of lung cancer using nano-nose-a review Open Biomed Eng J 2015 9 228 233
69. van der Schee M P Paff T Brinkman P van Aalderen W M Haarman E G Sterk P J Breathomics in lung disease Chest 2015 147 1 224 231
70. Davies M P Barash O Jeries R, et al. Unique volatolomic signatures of TP53 and KRAS in lung cells Br J Cancer 2014 111 6 1213 1221
71. Krilaviciute A Heiss J A Leja M Kupcinskas J Haick H Brenner H Detection of cancer through exhaled breath: a systematic review Oncotarget 2015 6 36 38643 38657
72. Went P T Lugli A Meier S, et al. Frequent EpCam protein expression in human carcinomas Hum Pathol 2004 35 1 122 128
73. Balzar M Winter M J de Boer C J Litvinov S V The biology of the 17-1A antigen (Ep-CAM) J Mol Med (Berl) 1999 77 10 699 712
74. Mattano L A Jr Moss T J Emerson S G Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction Cancer Res 1992 52 17 4701 4705
75. Nagrath S Sequist L V Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 2007 450 7173 1235 1239
76. Ilie M Hofman V Long-Mira E, et al. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease PLoS ONE 2014 9 10 e111597
77. Leon S A Shapiro B Sklaroff D M Yaros M J Free DNA in the serum of cancer patients and the effect of therapy Cancer Res 1977 37 3 646 650
78. Sozzi G Conte D Leon M, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer J Clin Oncol 2003 21 21 3902 3908
79. Sidransky D Emerging molecular markers of cancer Nat Rev Cancer 2002 2 3 210 219
80. Diehl F Li M Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors Proc Natl Acad Sci U S A 2005 102 45 16368 16373
81. Diehl F Schmidt K Choti M A, et al. Circulating mutant DNA to assess tumor dynamics Nat Med 2008 14 9 985 990
82. Diaz L A Jr Bardelli A Liquid biopsies: genotyping circulating tumor DNA J Clin Oncol 2014 32 6 579 586
83. Shinozaki M O'Day S J Kitago M, et al. Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy Clin Cancer Res 2007 13 7 2068 2074
84. Dawson S J Tsui D W Murtaza M, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer N Engl J Med 2013 368 13 1199 1209
85. Newman A M Bratman S V To J, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage Nat Med 2014 20 5 548 554
86. Newman A M Lovejoy A F Klass D M, et al. Integrated digital error suppression for improved detection of circulating tumor DNA Nat Biotechnol 2016 34 5 547 555
87. Lanman R B Mortimer S A Zill O A, et al. Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA PLoS ONE 2015 10 10 e0140712